Indeed, our data showed that treatment of MM cells with drugs targeting GSK3 led to a marked reduction of the constitutive STAT3 phosphorylation in Tyr705 and its binding to the promoter fragment encompassing a repressive MICA/STAT3 response element. The gene discussed is MICA; the disease is Miyoshi myopathy.